Danish participation in American cancer meeting
Bavarian, Genmab and Topotarget all provide a glimpse of the status of their pipelines by using the upcoming 2012 ASCO Annual Meeting to present clinical data from ongoing studies.
125 billion dollars. That’s the total amount spent on cancer treatments in the US in 2010 according to The National Institute of Health. A number that the institute expects will rise to 158 billion dollars in 2020.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Who will win the battle on cancer?
For abonnenter
